Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
11.54 USD | +1.81% | +2.72% | +2.54% |
05/04 | Arbutus Biopharma Obtains Favorable Court Order in Moderna Patent Lawsuit | MT |
04/04 | Moderna Suffers Setback in Lawsuit by Arbutus | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+2.54% | 9.13B | |
+31.37% | 588B | |
-3.07% | 364B | |
+19.49% | 326B | |
+5.36% | 285B | |
+14.83% | 239B | |
+9.93% | 210B | |
-6.95% | 200B | |
+10.28% | 167B | |
+0.18% | 161B |
- Stock Market
- Equities
- ROIV Stock
- News Roivant Sciences Ltd.
- Citigroup Adjusts Price Target on Roivant Sciences to $11 From $10, Maintains Buy Rating